Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer
Crossref DOI link: https://doi.org/10.1186/s12885-015-1630-1
Published Online: 2015-09-09
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Komatsu, Yoshito
Ishioka, Chikashi
Shimada, Ken
Yamada, Yasuhide
Gamoh, Makio
Sato, Atsushi
Yamaguchi, Tatsuro
Yuki, Satoshi
Morita, Satoshi
Takahashi, Shin
Goto, Rei
Kurihara, Minoru
License valid from 2015-09-09